These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 27209573)

  • 1. The impact of ischaemic stroke on atrial fibrillation-related healthcare cost: a systematic review.
    Li X; Tse VC; Au-Doung LW; Wong ICK; Chan EW
    Europace; 2017 Jun; 19(6):937-947. PubMed ID: 27209573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cost savings of newer oral anticoagulants in atrial fibrillation-related stroke prevention
.
    Masbah N; Macleod MJ
    Int J Clin Pharmacol Ther; 2017 Mar; 55(3):220-230. PubMed ID: 28025962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and cost of stroke and hemorrhage in patients diagnosed with atrial fibrillation in France.
    Cotté FE; Chaize G; Kachaner I; Gaudin AF; Vainchtock A; Durand-Zaleski I
    J Stroke Cerebrovasc Dis; 2014 Feb; 23(2):e73-83. PubMed ID: 24119623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of atrial fibrillation on stroke-related healthcare costs.
    Sussman M; Menzin J; Lin I; Kwong WJ; Munsell M; Friedman M; Selim M
    J Am Heart Assoc; 2013 Nov; 2(6):e000479. PubMed ID: 24275631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The budget impact of left atrial appendage closure compared with adjusted-dose warfarin and dabigatran etexilate for stroke prevention in atrial fibrillation.
    Amorosi SL; Armstrong S; Da Deppo L; Garfield S; Stein K
    Europace; 2014 Aug; 16(8):1131-6. PubMed ID: 24687964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost efficiency of anticoagulation with warfarin to prevent stroke in medicare beneficiaries with nonvalvular atrial fibrillation.
    Mercaldi CJ; Ciarametaro M; Hahn B; Chalissery G; Reynolds MW; Sander SD; Samsa GP; Matchar DB
    Stroke; 2011 Jan; 42(1):112-8. PubMed ID: 21148442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alcohol-related hospitalization is associated with increased risk of ischaemic stroke among low-risk patients with atrial fibrillation.
    Al-Khalili F; Benson L; Friberg L
    Europace; 2018 Jan; 20(1):19-24. PubMed ID: 28339885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modelling projections for the uptake of edoxaban in an European population to 2050: effects on stroke, thromboembolism, and health economics perspectives.
    Blann AD; Boriani G; Lip GY
    Europace; 2016 Oct; 18(10):1507-1513. PubMed ID: 27876695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Burden of stroke and other cardiovascular complications in patients with atrial fibrillation hospitalized in France.
    Cotté FE; Chaize G; Gaudin AF; Samson A; Vainchtock A; Fauchier L
    Europace; 2016 Apr; 18(4):501-7. PubMed ID: 26718532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of dabigatran versus vitamin K antagonists for the prevention of stroke in patients with atrial fibrillation: a French payer perspective.
    Chevalier J; Delaitre O; Hammès F; de Pouvourville G
    Arch Cardiovasc Dis; 2014; 107(6-7):381-90. PubMed ID: 24973113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stroke and thromboembolism in atrial fibrillation: a systematic review of stroke risk factors, risk stratification schema and cost effectiveness data.
    Hughes M; Lip GY;
    Thromb Haemost; 2008 Feb; 99(2):295-304. PubMed ID: 18278178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-vitamin K-dependent oral anticoagulants have a positive impact on ischaemic stroke severity in patients with atrial fibrillation.
    Hellwig S; Grittner U; Audebert H; Endres M; Haeusler KG
    Europace; 2018 Apr; 20(4):569-574. PubMed ID: 28460024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are cost benefits of anticoagulation for stroke prevention in atrial fibrillation underestimated?
    Miller PS; Andersson FL; Kalra L
    Stroke; 2005 Feb; 36(2):360-6. PubMed ID: 15637326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Annual costs attributed to atrial fibrillation management: cross-sectional study of primary healthcare electronic records.
    Casajuana M; Giner-Soriano M; Roso-Llorach A; Vedia C; Violan C; Morros R
    Eur J Health Econ; 2018 Nov; 19(8):1129-1136. PubMed ID: 29464418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing the economic burden of ischemic stroke patients with and without atrial fibrillation: a retrospective study in Beijing, China.
    Wen L; Wu J; Feng L; Yang L; Qian F
    Curr Med Res Opin; 2017 Oct; 33(10):1789-1794. PubMed ID: 28657348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost of acute stroke care for patients with atrial fibrillation compared with those in sinus rhythm.
    Ali AN; Howe J; Abdel-Hafiz A
    Pharmacoeconomics; 2015 May; 33(5):511-20. PubMed ID: 25693879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Causes of Ischemic Stroke in Patients with Non-Valvular Atrial Fibrillation.
    Nakamura A; Kuroda J; Ago T; Hata J; Matsuo R; Arakawa S; Kuwashiro T; Yasaka M; Okada Y; Kitazono T; Kamouchi M;
    Cerebrovasc Dis; 2016; 42(3-4):196-204. PubMed ID: 27111222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of economics and cost-effectiveness analyses of anticoagulant therapy for stroke prevention in atrial fibrillation in the US.
    von Schéele B; Fernandez M; Hogue SL; Kwong WJ
    Ann Pharmacother; 2013 May; 47(5):671-85. PubMed ID: 23606551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stop the clots, but at what cost? Pharmacoeconomics of dabigatran etexilate for the prevention of stroke in subjects with atrial fibrillation: a systematic literature review.
    Marshall S; Fearon P; Dawson J; Quinn TJ
    Expert Rev Pharmacoecon Outcomes Res; 2013 Feb; 13(1):29-42. PubMed ID: 23402443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The likelihood of decreasing strokes in atrial fibrillation patients by strict application of guidelines.
    Pisters R; van Oostenbrugge RJ; Knottnerus IL; de Vos CB; Boreas A; Lodder J; Prins MH; Crijns HJ; Tieleman RG
    Europace; 2010 Jun; 12(6):779-84. PubMed ID: 20348143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.